Travere Therapeutics
TVTX
#3177
Rank
โ‚น449.90 B
Marketcap
โ‚น4,687
Share price
-1.68%
Change (1 day)
47.01%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2026 (TTM): -โ‚น122.58

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น120.34. In 2025 the company made an earnings per share (EPS) of -โ‚น27.05 an increase over its 2024 EPS that were of -โ‚น382.49.

EPS history for Travere Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น122.58353.09%
2025-โ‚น27.05-92.93%
2024-โ‚น382.49154.66%
2023-โ‚น150.20-63.16%
2022-โ‚น407.6844.22%
2021-โ‚น282.67-10.09%
2020-โ‚น314.39
2018-โ‚น236.9664.94%
2017-โ‚น143.67
2015โ‚น336.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น17.73-85.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น88.63-26.36%๐Ÿ‡บ๐Ÿ‡ธ USA